Wang Yang, Hu Jia-Wen, Lv Yong-Bo, Chu Chao, Wang Ke-Ke, Zheng Wen-Ling, Cao Yu-Meng, Yuan Zu-Yi, Mu Jian-Jun
Department of Cardiology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi, China (mainland).
Med Sci Monit. 2017 Feb 13;23:790-795. doi: 10.12659/msm.899563.
Uric acid is the end product of purine metabolism. Metabolic disorders of uric acid are associated with many disease states. Substantial evidence suggests the possible role of uric acid as a mediator of high blood pressure. Elevated uric acid is closely associated with new onset essential hypertension in adolescents and prehypertension; and urate-lowering agents can significantly improve these early stages of hypertension. Uric acid also influences salt sensitivity of blood pressure through two phases. Local renin-angiotensin-aldosterone system activation initiates renal damage, arteriolopathy, and endothelium dysfunction, which is followed by the dysregulation of sodium homeostasis, thereby leading to increased salt sensitivity. In this review we summarize the available evidence to contribute to a better understanding of the casual relationship between uric acid and early or intermediate stages of hypertension. We hope our review can contribute to the prevention of hypertension or provide new insights into a treatment that would slow the progression of hypertension.
尿酸是嘌呤代谢的终产物。尿酸代谢紊乱与多种疾病状态相关。大量证据表明尿酸可能作为高血压的介质发挥作用。尿酸升高与青少年新发原发性高血压和高血压前期密切相关;降尿酸药物可显著改善高血压的这些早期阶段。尿酸还通过两个阶段影响血压的盐敏感性。局部肾素 - 血管紧张素 - 醛固酮系统激活引发肾损伤、小动脉病变和内皮功能障碍,随后钠稳态失调,从而导致盐敏感性增加。在本综述中,我们总结现有证据,以更好地理解尿酸与高血压早期或中期之间的因果关系。我们希望我们的综述有助于高血压的预防,或为减缓高血压进展的治疗提供新的见解。